Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2005

Why, when, and how spontaneous intracerebral hematomas should be operated

Mario N Carvi y Nievas

Med Sci Monit 2005; 11(1): RA24-31 :: ID: 13888

Abstract

Patients with spontaneous intracerebral hematomas experience higher mortality and suffer more severe defi cits than any other stroke subtype. Although signifi cant intracerebral hematoma (ICH)-related death and severe neurological defi cits arise from hematoma mass effect and intraventricular extension, further clinical deterioration related to rebleeding and/or perihematomal brain edema evelopment often occurs. Many studies have shown that the level of disability and mortality after ICH also depends on the Glasgow Coma Scale (GCS) score, hemorrhage size and patient age.Despite major advances in brain-imaging examination procedures, improvements in neurosurgical critical care, and refi nements in microsurgical techniques, only a few subgroups of patients with spontaneous intracerebral hematomas are usually listed as candidates for surgical treatment in the reported series. One of the most commonly used clinical indications for surgery is neurological deterioration, but this is also a predictor of poor outcome. The recognized trials on the surgical management of intracerebral hematomas make exhaustive analyses of neither the potential advantage of setting patient selection criteria nor the role of early-applied, modern, minimally invasive techniques. In addition, all over the world considerable differences in the treatment of spontaneous intracerebral hematomas make the physicians involved uncertain about the need for surgery. The aim of this paper is to provide clear statements concerning the surgical management of spontaneous intracerebral hematoma patients based on a detailed analysis of the literature and on own experience-based data.

Keywords: Cerebral Hemorrhage - diagnosis, Cerebral Hemorrhage - surgery, Glasgow Coma Scale, Neurosurgical Procedures, Risk Factors, Surgical Procedures, Minimally Invasive, Cerebral Hemorrhage - surgery, Glasgow Coma Scale, Neurosurgical Procedures, Risk Factors, Surgical Procedures, Minimally Invasive

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

In Press

23 Feb 2024 : Clinical Research  

Early Mobilization in Pediatric Critical Care: Exploring the Gap Between Theory and Practice in Saudi Arabia

Med Sci Monit In Press; DOI: 10.12659/MSM.942467  

0:00

01 Feb 2024 : Review article  

Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and C...

Med Sci Monit In Press; DOI: 10.12659/MSM.942923  

10 Jan 2024 : Clinical Research  

Efficacy of Bakri Intrauterine Balloon in Managing Postpartum Hemorrhage: A Comparative Analysis of Vaginal...

Med Sci Monit In Press; DOI: 10.12659/MSM.943072  

15 Jan 2024 : Clinical Research  

Comparison of Modified Shock Index and Shock Index for Predicting Massive Transfusion in Women with Primary...

Med Sci Monit In Press; DOI: 10.12659/MSM.943286  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750